2RUSSELL K S,STERN D F,POLVERINI P J,et al.Activation of ErbB receptors in vascular endothelium leads to angiogenesis[J].Am J Physiol,1999,277:H2205-H2211.
3HUANG Y Z,WANG Q,XIONG W C,et al.Erb is a protein concentrated at postsynaptic membranes that interacts with PSD-95[J].J Biol Chem,2001,276:19318-19326.
4OKOSHI K,NAKAYAMA M,YAN X,et al.Neuregulins regulate cardiac parasympathetic activity:muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion[J].Circulation,2004,110:713-716.
5ZHAO Y Y,SAWYER D R,BALIGA R R,et al.Neuregulins promote survival and growth of cardic myocytes.Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes[J].J Biol Chem,1998,273:10261-10269.
6ORR-URTREGER A,TRAKHTENBROT L,BENLEVY R,et al.Neural expression and chromosomal mapping of Neu differention factor to 8p12-8p21[J].Proc Natl Acad Sci USA,1993,90:1867-1871.
7FALLS D L.Neuregulins and the neuromuscular system:10 years of answers and questions[J].J Neurocytol,2003,32:619-647.
8HEART C M,KUBALAK S W,WANG Y,et al.Synergistic roles of neuregulin-1 and insulin-like growth factor-1 in activation of the phosphatidylinositol 3-kinase pathway and cardiac chamber morphogenesis[J].J Biol Chem,1999,274:37362-37369.
9ROHRBACH S,NIEMANN B,SILBER R E,et al.Neuregulin receptors erbB2 and erbB4 in failuring human myocardium-depressed expression and attenuated activation[J].Basic Res Cardiol,2005,100:240-249.
10ROHRBACH S,YAN X,WEINBERG E O,et al.Neuregulin in cardiac hypertrophy in rats with aortic stenosis.Differential expression of erbB2 and erbB4 receptors[J].Circulation,1999,100:407-412.
2Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature ,1988 ,332:78-81.
3Chen H H, Burnett J C. Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep, 2000,2: 198-205.
4Maisel A S, Krishnaswamy P, Nowak R M, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med,2002 ,347:161-167.
5Roul G, Germain P, Bareiss P. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J,1998 ,136:449-457.
6WIECZOREK S J, WU A H, CHRISTENSON R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation[J]. Am Heart J, 2002 ,144:834-839.
7MAISEL A. B-type natriuretic peptide levels: diagnostic and therapeutic potential[J]. Cardiovasc Toxicol , 2001,1:159-164.
8RY S D, CLERICO A, GIANNESSI D, et al. Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method[J]. Scand J Clin Lab Invest,2000,60:81-90.
9HAMMERER-LERCHER A, NEUBAUER E,MULLER S, et al. Head-to-head comparison of N-terminal pro-BNP,BNP,and Nt-proANP in diagnosing left ventricular dysfunction [J]. Clin Chim Acta,2001,310: 193-197.
10MUELLER T, GEGENHUBER A, POELZ W, et al. Diagnostie aeeuraey of B type natriuretie peptide and amino terminal proBNP in the emergeney diagnosis of heart failure[J]. Heart, 2005,91:606-612.
